Professor Philip Rosenstiel, W3 Professor of Clinical Molecular Biology, Director, Institute of Clinical Molecular Biology (IKMB), Kiel University

Add to your list(s) Download to your calendar using vCal

• Prof Philip Rosenstiel, W3 Professor of Clinical Molecular Biology, Director, Institute of Clinical Molecular Biology (IKMB), Kiel University
• Thursday 14 May 2026, 16:00-17:00
• Lecture Theatre, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus.

If you have a question about this talk, please contact Liat Churley.

This Cambridge Immunology Network Seminar will take place on Thursday 14th May 2026, starting at 4:00pm, in the Ground Floor Lecture Theatre, Jeffrey Cheah Biomedical Centre (JCBC)

Speaker: Prof Philip Rosenstiel, W3 Professor of Clinical Molecular Biology, Director, Institute of Clinical Molecular Biology (IKMB), Kiel University (CAU) / UKSH , Germany

Short Bio: Philip Rosenstiel is the recipient of a Schleswig-Holstein Excellence Chair in Clinical Molecular Biology and Head of the Systems Immunology Group at the Institute of Clinical Molecular Biology, Kiel University since 2016. His research is focused on the interaction of the intestinal mucosa with the resident microbiome as an explanatory model of how the environment shapes disease susceptibility. His team is specialized in chronic inflammation and investigates cellular and murine inflammation models as well as large scale patient cohorts using state-of-the-art genomic techniques. He heads the Competence Centre for Genomic Analysis, which represents one of four German National NGS Sequencing Hubs of the DFG . To date, he has published >450 articles in peer-reviewed journals (H-index: 118 (Google scholar); citations: >90,000). Among other involvements, Philip is coordinator of the Horizon Europe research network PerPrev-CID, co-coordinates the IMI2 proposal ImmUniverse and is member of the steering board of the DFG Excellence Cluster Precision Medicine in Chronic Inflammation. He has acquired >40 million EUR of grant support. He has been elected as vice dean for research at the medical faculty of Kiel University and as head of the governing board for clinical translational research of Kiel and Lübeck University (Precision Health in Schleswig-Holstein, PHSH ). He acts as ad-hoc reviewer for journals (incl. NEJM , Nature, Science, Cell, Immunity, Cell Metabolism, Nature Immunology) and grant committees (DFG, INSERM , MRC, EU)

Title: To be confirmed

Host: Prof Arthur Kaser, Professor of Gastroenterology, Cambridge University

Refreshments will be available following the seminar.

This talk is part of the Cambridge Immunology Network Seminar Series series.

This talk is included in these lists:

• Lecture Theatre, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus
• All Talks (aka the CURE list)
• Cambridge Immunology
• Cambridge Immunology Network Seminar Series
• Cambridge Infectious Disease
• Cambridge Infectious Diseases
• LMB
• Liam

Note that ex-directory lists are not shown.